Company profile for Algen Biotechnologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Algen Biotechnologies is a pioneering drug-discovery company harnessing CRISPR, single-cell functional genomics and AI to decode disease-driving gene networks and deliver safer, more effective therapies. Inspired by research from the lab of Nobel Laureate Jennifer Doudna and supported by world-class scientific leadership, we apply precision gene modulation and deep-learning analytics to identify novel targets for cancer and in...
Algen Biotechnologies is a pioneering drug-discovery company harnessing CRISPR, single-cell functional genomics and AI to decode disease-driving gene networks and deliver safer, more effective therapies. Inspired by research from the lab of Nobel Laureate Jennifer Doudna and supported by world-class scientific leadership, we apply precision gene modulation and deep-learning analytics to identify novel targets for cancer and inflammation. Algen’s mission is to transform patient outcomes by translating high-confidence biology into next-generation medicines.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
665 3rd St Ste 280, San Francisco, California, 94107
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/lifespan-backed-algen-biotechnologies-partners-with-astrazeneca-to-advance-ai-drug-discovery-302579921.html

PR NEWSWIRE
09 Oct 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-inks-555-million-gene-editing-technology-deal-with-algen-ft-reports-2025-10-06/

REUTERS
06 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty